1. Home
  2. NTRA vs EXPD Comparison

NTRA vs EXPD Comparison

Compare NTRA & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • EXPD
  • Stock Information
  • Founded
  • NTRA 2003
  • EXPD 1979
  • Country
  • NTRA United States
  • EXPD United States
  • Employees
  • NTRA N/A
  • EXPD N/A
  • Industry
  • NTRA Medical Specialities
  • EXPD Oil Refining/Marketing
  • Sector
  • NTRA Health Care
  • EXPD Consumer Discretionary
  • Exchange
  • NTRA Nasdaq
  • EXPD Nasdaq
  • Market Cap
  • NTRA 20.6B
  • EXPD 16.8B
  • IPO Year
  • NTRA 2015
  • EXPD N/A
  • Fundamental
  • Price
  • NTRA $164.72
  • EXPD $121.46
  • Analyst Decision
  • NTRA Strong Buy
  • EXPD Sell
  • Analyst Count
  • NTRA 17
  • EXPD 11
  • Target Price
  • NTRA $145.00
  • EXPD $118.67
  • AVG Volume (30 Days)
  • NTRA 1.5M
  • EXPD 1.3M
  • Earning Date
  • NTRA 11-12-2024
  • EXPD 11-05-2024
  • Dividend Yield
  • NTRA N/A
  • EXPD 1.18%
  • EPS Growth
  • NTRA N/A
  • EXPD N/A
  • EPS
  • NTRA N/A
  • EXPD 5.12
  • Revenue
  • NTRA $1,531,955,000.00
  • EXPD $9,923,578,000.00
  • Revenue This Year
  • NTRA $42.99
  • EXPD $11.55
  • Revenue Next Year
  • NTRA $13.31
  • EXPD $0.84
  • P/E Ratio
  • NTRA N/A
  • EXPD $23.56
  • Revenue Growth
  • NTRA 54.94
  • EXPD N/A
  • 52 Week Low
  • NTRA $53.62
  • EXPD $111.20
  • 52 Week High
  • NTRA $171.95
  • EXPD $131.59
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 74.09
  • EXPD 51.62
  • Support Level
  • NTRA $143.20
  • EXPD $117.78
  • Resistance Level
  • NTRA $167.79
  • EXPD $121.37
  • Average True Range (ATR)
  • NTRA 7.08
  • EXPD 2.55
  • MACD
  • NTRA 3.87
  • EXPD 0.12
  • Stochastic Oscillator
  • NTRA 94.92
  • EXPD 60.51

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About EXPD Expeditors International of Washington Inc.

Expeditors International of Washington is a non-asset-based third-party logistics provider, focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 34% of consolidated net revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.

Share on Social Networks: